head and neck cancer

Research Reports
Development of a Low Resource Tool for Optimizing Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System
10/18/2019
Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...
Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...
Abstract: The Veterans...
10/18/2019
Journal of Clinical Pathways
News
Nanobiotix Partner PharmaEngine Launches NBTXR3 Clinical Trial in Head and Neck Cancers in Asia
10/26/2016
Seventh clinical trial with NBTXR3 in a new population of patients with head and neck cancers treated with radiotherapy plus chemotherapyParis, France, and Cambridge, Massachusetts, USA, October 20, 2016 – NANOBIOTIX (Euronext: NANO – ISIN:...
Seventh clinical trial with NBTXR3 in a new population of patients with head and neck cancers treated with radiotherapy plus chemotherapyParis, France, and Cambridge, Massachusetts, USA, October 20, 2016 – NANOBIOTIX (Euronext: NANO – ISIN:...
Seventh clinical trial with...
10/26/2016
IO Learning
Research in Review
Nivolumab Superior to Standard Therapy for Recurrent Head and Neck Cancer
10/14/2016
JCP Editors
Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in...
Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in...
...
10/14/2016
Journal of Clinical Pathways
News
Postoperative Stereotactic Radiosurgery a New Standard of Care for Patients With Resected Brain Metastases
09/27/2016
Newswise — BOSTON, September 25, 2016 -- For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life...
Newswise — BOSTON, September 25, 2016 -- For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life...
Newswise — BOSTON, September 25,...
09/27/2016
IO Learning
News
Stereotactic Radiosurgery Decreases Rate of Postoperative Local Recurrence for Brain Metastases
09/27/2016
Alternative to whole brain radiation therapy improved local control but did not augment overall survival or rate of distant metastasesNewswise — BOSTON, September 25, 2016 -- Stereotactic radiosurgery (SRS) for cancer patients who receive the...
Alternative to whole brain radiation therapy improved local control but did not augment overall survival or rate of distant metastasesNewswise — BOSTON, September 25, 2016 -- Stereotactic radiosurgery (SRS) for cancer patients who receive the...
Alternative to whole brain...
09/27/2016
IO Learning
Research in Review
Systemic Therapy Use Growing Among Elderly Patients With Head and Neck Cancer
08/12/2016
JCP Editors
Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study...
Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study...
...
08/12/2016
Journal of Clinical Pathways
Nivolumab More than Doubles One-Year Overall Survival in Head/Neck Cancer
04/27/2016
JCP Editors
Treatment with nivolumab reduced the risk of death and improved one-year overall survival (OS) compared with investigator’s choice of therapy for patients with recurrent or metastatic head and neck squamous cell...
Treatment with nivolumab reduced the risk of death and improved one-year overall survival (OS) compared with investigator’s choice of therapy for patients with recurrent or metastatic head and neck squamous cell...
...
04/27/2016
Journal of Clinical Pathways
Research in Review
Number of Positive Nodes Best Prognostic Indicator for Patients With Head and Neck Cancer
04/11/2016
JCP Editors
The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent...
The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent...
The...
04/11/2016
Journal of Clinical Pathways
Research in Review
HPV-16 Associated with Better Overall Survival in Patients With Head and Neck Cancer
03/31/2016
JCP Editors
The presence of human papillomavirus-16 (HPV-16) is associated with higher rates of overall survival in patients with head and neck squamous cell carcinoma (HNSC), suggesting it may be a more effective prognostic...
The presence of human papillomavirus-16 (HPV-16) is associated with higher rates of overall survival in patients with head and neck squamous cell carcinoma (HNSC), suggesting it may be a more effective prognostic...
The...
03/31/2016
Journal of Clinical Pathways
Research in Review
PET-CT Scans More Cost-Effective Than Surgery for Head and Neck Cancer
03/28/2016
JCP Editors
Surveillance using positron emission tomography-computed tomography (PET-CT) scans can be a cost-effective and safe alternative to invasive neck dissection for certain patients with head and neck cancer (HNC),...
Surveillance using positron emission tomography-computed tomography (PET-CT) scans can be a cost-effective and safe alternative to invasive neck dissection for certain patients with head and neck cancer (HNC),...
...
03/28/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use